Kilian Guse, PhD

CEO, Co-Founder

Kilian Guse

Dr. Guse has more than 10 years experience in the field of gene therapy and is author of more than 30 scientific publications in international, peer-reviewed journals and book chapters on this topic.

He holds a PhD in gene therapy from the University of Helsinki, Finland and has done postdoctoral training at Baylor College of Medicine in Houston, USA.

He has also spent short periods working at Bayer Australia and Jennerex Biotherapeutics, now SillaJen, a biotech company focused on the development of gene therapy for cancer. Dr. Guse studied pharmacy at the Goethe University in Frankfurt, Germany.